You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH):分公司獲得化學原料藥上市申請批准通知書
格隆匯 06-25 18:15

格隆匯6月25日丨珍寶島(603567.SH)公佈,公司雞西分公司收到國家藥品監督管理局頒發的《化學原料藥上市申請批准通知書》,富馬酸盧帕他定是一種長效抗組胺劑,通過選擇性拮抗組胺H1 受體發揮作用。本品能抑制致敏細胞脱顆粒及炎性細胞因子的釋放,具有抗過敏特性。盧帕他定為第二代抗組胺藥物,是一種長效、選擇性外周H1 受體拮抗劑。藥物在體內的一些代謝產物(地氯雷他定及其羥基代謝物)仍然具有抗組胺活性,有利於增強整體藥效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account